“If patients are using other wearable tools like Fitbit, Apple Watch and other wearable tracking sensors, the data can be connected. We are integrative and collaborative with other tools,” Komathi Stem, MS, founder and CEO of monARC Bionetworks, said in the interview. (Read more…)
monARC Bionetworks’ new app enables patients to track symptoms between clinic visits - while also passively collecting environmental data, such as location and air quality…
This year’s Revolutionizing Atopic Dermatitis conference just concluded in Chicago. We came away with valuable lessons on the importance of starting any health technology solution, as well as the journey to better therapies, with the patient’s everyday experience today. I don’t just mean their experience with the condition, but also their experience with how medicine is organized and practiced today…
One question dominated the conversation at last week’s Becker’s Hospital Review Annual Meeting: What can healthcare systems learn from the success of the tech behemoths that are now positioning themselves to enter healthcare? We are excited by the answer…
monARC Bionetworks launches the monARC App to empower patients to track their symptoms between clinic visits to inform better healthcare decisions and simplify research participation. Beyond tracking symptoms, patients can use it to capture the impact of their condition on daily activities…
“monARC was founded on the principle of making health data more accessible both to the individual as well as the larger research and health community,” said Komathi Stem, CEO and founder of monARC Bionetworks. “The motivation for the new monARC Smart Health Record is to provide a tool to visualize and manage one’s comprehensive health data, and enable users to effortlessly share their information to accelerate research”…
Among the many vexing issues faced by companies that conduct clinical trials, at least two of them — the large number of participants needed for trials and participants’ fears they will be end up getting a placebo — can be eased by using an innovative approach to collecting comparison data called synthetic control arms. With the skyrocketing cost of clinical trials, the proliferation of digital data, and a new FDA commitment to considering real-world data in regulatory decision making…
With only 5 percent of qualified patients participating in trials and another 85 percent wanting to participate, Komathi Stem, biomedical engineer and founder of monARC Bionetworks, is hopeful that technology can change this.
The new generation of mobile devices and apps have changed the traditional concept of a medical device being purely and exclusively an instrument or system that interacts with a patient and used within a hospital setting or physician’s office.5 In addition to the commercial use of digital technology, there is a growing trend toward using it for clinical studies. Clinical trial software companies have been gaining momentum like TransMed Systems in Oncology and monARC Bionetworks in interstitial lung disease. Today, mobile…
Komathi Stem discussed the need for a paradigm shift in the healthcare ecosystem from prioritizing data ownership to data access. monARC is creating a new world where patients own their data and are fully vested in sharing their data with researchers to accelerate the search for new treatments or cures. She shared how monARC's Smart Health Record engages patients early and continuously to share their EHR data directly with researchers to inform trial designs and prequalify for trials. This direct collaboration with patients has reduced screening time and effort…
Cool Vendors in Life Sciences, 2018
The company that’s on a mission to modernize the clinical research industry by empowering patients to share their data and participate anytime, anywhere. They are the first company to develop a proprietary “Smart Health Record”, consolidating patient data from Electronic Health Records (EHRs) and other sources, including mobile apps into a metadata rich record that informs study protocol design and provides pre-screening analytics capabilities for clinical trials. The monARC Smart Health Record™ makes enrollment…
“Our goal is to provide tools that allow every patient, no matter where they live, to fully participate in the entire PF community,” Gregory P. Cosgrove, MD, chief medical officer for the PFF, said in a press release. “PF Health not only eliminates geographic limitations, it also enables patients to lead the effort to transform research.”
Built by monARC Bionetworks with input from the PF community during its development phase, PF Health also puts the trusted and latest resources from the PFF directly into the hands of patients and their families. In addition, the app provides an important data collection tool, inviting patients to share de-identified data that will be utilized in PF research.
Stem—monARC’s founder and CEO—and her multidisciplinary team has created a digital end-to-end clinical trial platform that makes it possible for patients to get trial ready and to participate in clinical research from anywhere, anytime by leveraging telemedicine and mobile technologies. By allowing patients to directly donate their data, monARC is creating a new data-sharing economy that will transform the highly sequential and siloed drug development model into an integrated and a collaborative model with patients.
"Roivant's drug development team supports the companies in our family as they develop innovative medicines in their respective therapeutic areas," said William T. Symonds, PharmD, Chief Development Officer at Roivant. "monARC's capabilities will enhance the design and conduct of our own clinical trials, as well as trials conducted by other companies and institutions."
Komathi Stem, MSE, founder and CEO of monARC Bionetworks, speaks to the possibilities: “The sheer tsunami of health care data available from medical records and the growing use of mobile and digital sensor technologies to collect health data, combined with rising online patient engagement in health care and research, present an unprecedented opportunity to modernize clinical trials through greater collaboration with patients and their clinical care systems.”
The data in electronic health records overlaps with the types of data collected for clinical research. Komathi Stem, MSE, founder and CEO of monARC Bionetworks, speaks to the possibilities: “The sheer tsunami of health care data available from medical records and the growing use of mobile and digital sensor technologies to collect health data, combined with rising online patient engagement in health care and research, present an unprecedented opportunity to modernize clinical trials through greater collaboration with patients and their clinical care systems.”
MonARC Bionetworks and the Pulmonary Fibrosis Foundation have partnered to bring the IPF community the PF Health app – a monumental partnership that will bring clinical research opportunities directly to the PF community.
A new partnership with monARC Bionetworks (monARC), a digital research company committed to accelerating pulmonary fibrosis research, was also announced. The PFF and monARC launched the beta version of a mobile app, PF Health, to accelerate clinical trials and research for pulmonary fibrosis by making it simpler for patients to share their health data with researchers anytime, anywhere. In addition, the PF Health app will provide access to the Foundation’s information and trusted educational materials. PF Health is available on the iTunes App Store.
Pulmonary Fibrosis Foundation Announcement: "We announced a new partnership with monARC Bionetworks (monARC), a digital research company, at the #PFFSummit. monARC accelerates clinical trials by making it simpler for patients to share their data directly with researchers to advance understanding of the disease and help more patients participate in research anytime, anywhere. Together, we launched the beta version of a mobile app, PF Health, which is downloadable from the iTunes App Store here."
monARC activates Patient Research Networks powered with a transformative data collection and analytics platform that converges data from clinical care and digital devices (smartphones and sensors) into a Smart Health Record. The Smart Health Record is a holistic, computable, longitudinal medical record that generates deep insights to inform trial designs and stratify patients. In addition, the platform leverages telemedicine and mobile technologies to facilitate trial participation from anywhere, anytime.
monARC wants to make clinical trial patients feel less like customers going through a transaction and more like active participants.
Use the PF Health mobile app to: Track and trend your IPF related symptoms, record your spirometry values to help monitor the progression of your pulmonary fibrosis, monitor and trend your weight over time, keep up-to-date with the latest pulmonary fibrosis news and resources, pre-qualify for any upcoming IPF Clinical Trials, and more.
The Pulmonary Fibrosis Warriors (PF Warriors) and monARC Bionetworks teamed up to host a Facebook Live video, sharing important information about how patients can become more involved in research and more in control of their own health.
Nearly 250 people in attendance to watch Plenary Event, where six women leaders in the life sciences delivered pitches and received valuable feedback from top female investors on presentation and delivery.
Scientists aren’t always the best at sharing amongst themselves. But sharing data could mean accelerated research. By making your own data available to scientists you can help contribute to a more holistic record, and by default, stimulate the research process. This is the theory monARC Bionetworks stands by.
Regional and national leaders in rare diseases, health technologies, and clinical trials will demonstrate how to leverage new tools and technologies to enhance patient partnership, reduce the burden of participation in clinical research, and accelerate development of new therapeutics.
monARC Bionetworks’ will present on how its approach to patient centric research transforms a sequential and siloed drug development model into an integrated and collaborative data sharing model between patients, providers, and researchers without sacrificing the principles of evidence based medicine.